Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system von GAUNTT, C. J, GUDVANGEN, R. J, BRANS, Y. W, MARLIN, A. E

Volltext

Levamisole exacerbates coxsackievirus B3-induced murine myocarditis von GUDVANGEN, R. J, DUFFEY, P. S, PAQUE, R. E, GAUNTT, C. J

Volltext

Murine forebrain anomalies induced by coxsackievirus B3 variants von Gauntt, C. J., Jones, D. C., Huntington, H. W., Arizpe, H. M., Gudvangen, R. J., Deshambo, R. M.

Volltext

Cellular immune responses in mice challenged with an amyocarditic variant of coxsackievirus B3 von Lutton, C. W., Gudvangen, R. J., Nealon, T. J., Paque, R. E., Gauntt, C. J.

Volltext

Temperature-Sensitive Mutant of Coxsackievirus B3 Establishes Resistance in Neonatal Mice That Protects Them During Adolescence Against Coxsackievirus B3-Induced Myocarditis von Gauntt, C J, Paque, R E, Trousdale, M D, Gudvangen, R J, Barr, D T, Lipotich, G J, Nealon, T J, Duffey, P S

Volltext

Cellular immune response in mice challenged with an amyocarditic variant of coxsackievirus B3 von LUTTON, C. W, GUDVANGEN, R. J, NEALON, T. J, PAQUE, R. E, GAUNTT, C. J

Volltext

Levamisole exacerbates coxsackievirus B3-induced murine myocarditis von Gudvangen, R J, Duffey, P S, Paque, R E, Gauntt, C J

Volltext

Practical and Scalable Two-Step Process for 6‑(2-Fluoro-4-nitrophenyl)-2-oxa-6-azaspiro[3.3]heptane: A Key Intermediate of the Potent Antibiotic Drug Candidate TBI-223 von Cardoso, Flavio S.P., Kadam, Appasaheb L., Nelson, Ryan C., Tomlin, John W., Dahal, Dipendra, Kuehner, Christopher S., Gudvangen, Gard, Arduengo, Anthony J., Burns, Justina M., Aleshire, Sarah L., Snead, David R., Qu, Fengrui, Belmore, Ken, Ahmad, Saeed, Agrawal, Toolika, Sieber, Joshua D., Donsbach, Kai Oliver

Volltext